
413 FIBROTEST (FT) VALUE INDEPENDENTLY PREDICTS EARLY (EVR) AND SUSTAINED VIROLOGICAL RESPONSE (SVR) IN NON-RESPONDER PATIENTS RE-TREATED WITH PEGYLATED INTERFERON ALFA-2B (PEG-2B) AND RIBAVIRIN IN EPIC3
T. Poynard, E.R. Schiff, R. Terg, R. Moreno-Otero, S.L. Flamm, W. Schmidt, T. Berg, F.L. Goncales, J.E. Heathcote, M. Diago, T. McGarrity, P. Bedossa, H. Zhou, P. Mukhopadhyay, L.H. Griffel, M. BurrouVolume:
50
Année:
2009
Langue:
english
DOI:
10.1016/s0168-8278(09)60415-3
Fichier:
PDF, 53 KB
english, 2009